TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
TriLink BioTechnologies, part of Maravai LifeSciences, opened a GMP enzyme manufacturing facility in Jupiter, Florida, designed to support integrated IVT supply from R&D to commercial scale. The facility offers a coordinated, single-source package of enzymes, nucleotides, and cap analogs, aiming to simplify sourcing and reduce manufacturing risks for RNA developers.
Key figures
- Ds RNA reduction
- 85%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.